Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 508,940 | 462,021 | 442,996 | 448,308 | 466,569 |
| Cost of Goods | 216,225 | 203,830 | 202,370 | 201,578 | 206,026 |
| Gross Profit | 292,715 | 258,191 | 240,626 | 246,730 | 260,543 |
| Operating Expenses | 170,376 | 166,778 | 157,171 | 158,849 | 156,407 |
| Operating Income | 122,564 | 92,243 | 83,825 | 88,459 | 104,162 |
| Interest Expense | 9,155 | 8,589 | 7,755 | 7,786 | 8,204 |
| Other Income | 1,176 | 1,083 | 1,057 | 851 | 928 |
| Pre-tax Income | 114,585 | 84,737 | 77,127 | 81,524 | 96,886 |
| Income Tax | 29,178 | 15,679 | 24,756 | 25,072 | 29,680 |
| Net Income Continuous | 85,407 | 69,058 | 52,371 | 56,452 | 67,206 |
| Minority Interests | 50 | 39 | 2 | -3 | 4 |
| Net Income | $85,357 | $69,019 | $52,369 | $56,455 | $67,202 |
| EPS Basic Total Ops | 0.97 | 0.78 | 0.58 | 0.63 | 0.75 |
| EPS Basic Continuous Ops | 0.97 | 0.78 | 0.59 | 0.63 | 0.75 |
| EPS Diluted Total Ops | 0.95 | 0.77 | 0.57 | 0.62 | 0.74 |
| EPS Diluted Continuous Ops | 0.95 | 0.77 | 0.58 | 0.62 | 0.74 |
| EBITDA(a) | $143,150 | $112,550 | $104,909 | $108,226 | $123,826 |